A lengthy New York Times report yesterday detailed just how much more Americans pay for medical services than people in other countries. Often a lot more: almost twice what the Swiss pay for a colonoscopy, three and a half times more than the Dutch for an MRI and five times more than Spaniards for a hip replacement, according to the International Federation of Health Plans.
The high per-unit price of medical services in this country is an open secret, well documented in the health-policy world but largely ignored in the political debate. Rather than rail against high prices, Americans should rail against this: The fixes for those higher prices are clear enough, yet they get almost no consideration from policymakers.
The rash of recent proposals to slow health-care spending have focused on reducing the use of health-care services or shifting those costs to beneficiaries, rather than bringing down per-unit costs. Take the Bowles-Simpson report from December 2010: The largest proposed Medicare savings came from asking the elderly to pay more for their care. Other reports take a similar approach.
Read the full story here: http://bloom.bg/13A1P75
Source: Bloomberg News
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
For Neuromuscular Disease Community, an Era of Opportunities and Threats
March 17th 2025Robert Califf, MD, former commissioner of the FDA, delivered a keynote address at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference that highlighted the enormous opportunities for progress in neuromuscular disease care amid a changing policy environment.
Read More
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More
Oz Confirmation Hearing Probes Vision for Medicaid but Coalesces Around Well-Being
March 14th 2025Mehmet Oz, MD, the nominee to lead CMS under the Trump administration, testified in a confirmation hearing before the Senate Finance Committee, where he found common ground on improving outcomes through healthier lifestyle choices but encountered repeated questions on potential Medicaid cuts.
Read More